GENEVA, Nov. 6 -- GILEAD SCIENCES, INC. filed a patent application (US2026/026010) for “CDK2/CYCLIN E1 INHIBITOR COMPOUNDS AND USES THEREOF”. With publication no. WO/2026/231919, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 519/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....